FDA Issues Emergency Use Authorization for MatMaCorp’s COVID-19 2SF RNA Test for the Detection of SARS-CoV-2
MatMaCorp a member of Bio Nebraska, announced that the U.S. FDA has granted Emergency Use Authorization of MatMaCorp’s COVID-19 2SF RNA test for the detection of SARS-CoV-2 on the company’s Solas 8® portable detection system. Read more